Understanding The Potential Drug Target and Biomarker of CYC1

Target Name: CYC1

NCBI ID: G1537

CYC1

Understanding The Potential Drug Target and Biomarker of CYC1

CYC1, also known as cytochrome c-1, is a protein that is expressed in various cell types of the body. It plays a critical role in the detoxification of harmful substances, such as drugs and other toxins, in the liver. CYC1 is also involved in the regulation of cell signaling pathways and is a potential drug target for several diseases.

The drug target potential of CYC1 is due to its unique structure and function. CYC1 is a cytochrome, which is a protein that is composed of a central heme group and two side chains. The cytochrome ring is the most stable part of the protein and is responsible for the chemical reaction that allows it to detoxify harmful substances. The side chains of CYC1 are involved in the regulation of the chemical reaction and in the transport of the heme group to the cytochrome ring.

CYC1 is expressed in various cell types of the body, including the liver, where it is responsible for the detoxification of drugs and other toxins. The liver is a vital organ that is responsible for removing harmful substances from the body, and CYC1 plays a critical role in this process. When a substance is ingested or injected into the body, it is carried to the liver by the bloodstream. The liver then recognizes the substance and sends a signal to the CYC1 protein to begin the detoxification process.

CYC1 is involved in the regulation of cell signaling pathways, which are the rules that govern the flow of information within a cell. It is a crucial regulator of the production of reactive oxygen species (ROS), which are free radicals that can cause damage to cells and contribute to the development of several diseases, including cancer. CYC1 helps to maintain a balance of ROS and protects cells from oxidative stress.

CYC1 is also involved in the regulation of cell apoptosis, which is the process by which cells die naturally. Apoptosis is a natural process that helps to remove damaged or dysfunctional cells from the body. CYC1 plays a critical role in this process by regulating the production of pro-apoptotic signaling molecules, which can cause cells to die naturally.

CYC1 is a potential drug target for several diseases, including cancer, because of its involvement in the detoxification of harmful substances and its regulation of cell signaling pathways and apoptosis. CYC1 has been shown to be involved in the development and progression of several types of cancer, including liver cancer, breast cancer, and colorectal cancer.

In addition to its potential as a drug target, CYC1 is also a valuable biomarker for several types of cancer. The cytochrome ring of CYC1 is a unique protein that can be used as a specific and sensitive indicator of the level of a drug in the body. This makes it an attractive potential biomarker for the treatment of cancer.

CYC1 is also involved in the regulation of the production of other harmful substances, such as heavy metals and other toxins. This makes it an important protein for the detoxification of these substances and for the prevention of neurotoxicity.

In conclusion, CYC1 is a protein that is expressed in various cell types of the body and plays a critical role in the detoxification of harmful substances and the regulation of cell signaling pathways and apoptosis. Its unique structure and function make it an attractive potential drug target and a valuable biomarker for the treatment of cancer. Further research is needed to fully understand the role of CYC1 in the detoxification of harmful substances and the prevention of disease.

Protein Name: Cytochrome C1

Functions: Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. The cytochrome b-c1 complex catalyzes electron transfer from ubiquinol to cytochrome c, linking this redox reaction to translocation of protons across the mitochondrial inner membrane, with protons being carried across the membrane as hydrogens on the quinol. In the process called Q cycle, 2 protons are consumed from the matrix, 4 protons are released into the intermembrane space and 2 electrons are passed to cytochrome c. Cytochrome c1 is a catalytic core subunit containing a c-type heme. It transfers electrons from the [2Fe-2S] iron-sulfur cluster of the Rieske protein to cytochrome c

The "CYC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets